亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Current status of blood component therapy in surgical critical care

医学 重症监护医学 促红细胞生成素 贫血 输血 败血症 临床试验 血液管理 随机对照试验 外科 内科学
作者
Lena M. Napolitano
出处
期刊:Current Opinion in Critical Care [Ovid Technologies (Wolters Kluwer)]
卷期号:10 (5): 311-317 被引量:35
标识
DOI:10.1097/01.ccx.0000140948.98019.8a
摘要

The use of blood component therapy, with transfusion of red cells, plasma, and platelets, is common in critical care. New evidence has emerged documenting the risks associated and lack of efficacy or improvement in clinical outcome with blood transfusion for the treatment of anemia in critically ill patients who are hemodynamically stable.The safety of a restrictive transfusion strategy (transfuse only if hemoglobin < 7 g/dL) was reported in 1999. Despite compelling evidence from this prospective randomized clinical trial, clinicians have not substantially changed practice regarding blood transfusion in critical care. The recently published CRIT trial reported that the mean pre-transfusion hemoglobin was 8.6 g/dL in this large multicenter trial that examined transfusion practices in critical care in the US. Furthermore, only 19% of hospitals had an institutional blood transfusion protocol. The Surviving Sepsis Campaign guidelines have also recommended blood transfusion only when hemoglobin falls to 7.0 g/dL, following resolution of tissue hypoperfusion and in the absence of significant coronary artery disease or acute hemorrhage. We have an increased understanding of the pathophysiology of the anemia associated with critical care, related to the inflammatory response, downregulation of erythropoietin, and lack of iron availability due to macrophage sequestration. Clinical trials are underway to confirm the efficacy of recombinant erythropoietin in the treatment of critically ill patients with anemia.Current data regarding blood transfusion thresholds and risks of blood transfusion have not as yet significantly altered practice patterns. Efforts to reduce blood transfusion rates in critically ill patients are required. These strategies will require education, unit and institutional protocols, and reduction of phlebotomy for diagnostic laboratory testing in the intensive care unit. Further investigations regarding anemia in critical care and new treatment and prevention strategies are required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
猫七发布了新的文献求助10
2秒前
雷桑发布了新的文献求助10
4秒前
潘善若完成签到,获得积分10
5秒前
8秒前
麦子要当写手完成签到,获得积分10
12秒前
14秒前
喵喵发文章啦完成签到 ,获得积分10
15秒前
cc完成签到,获得积分10
17秒前
完美世界应助1461644768采纳,获得10
21秒前
我爱学习完成签到 ,获得积分10
26秒前
藤椒辣鱼应助mmyhn采纳,获得10
27秒前
27秒前
丘比特应助留胡子的代芙采纳,获得10
30秒前
30秒前
平常远山发布了新的文献求助10
32秒前
34秒前
wym完成签到,获得积分10
41秒前
平常远山完成签到,获得积分10
43秒前
47秒前
1461644768发布了新的文献求助10
51秒前
桂花完成签到,获得积分10
53秒前
天天快乐应助小白采纳,获得10
57秒前
桂花发布了新的文献求助10
58秒前
SYLH应助1461644768采纳,获得10
1分钟前
优雅的盼夏完成签到,获得积分10
1分钟前
1分钟前
飞羽发布了新的文献求助10
1分钟前
科研冰山完成签到 ,获得积分10
1分钟前
可爱的函函应助桂花采纳,获得10
1分钟前
Abel完成签到,获得积分10
1分钟前
1分钟前
小白发布了新的文献求助10
1分钟前
要开心吖完成签到 ,获得积分10
1分钟前
Owen应助科研通管家采纳,获得10
1分钟前
可爱的函函应助wpj采纳,获得10
1分钟前
NS完成签到,获得积分10
1分钟前
1分钟前
两个我完成签到 ,获得积分10
1分钟前
相龙发布了新的文献求助10
1分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3460014
求助须知:如何正确求助?哪些是违规求助? 3054351
关于积分的说明 9041785
捐赠科研通 2743636
什么是DOI,文献DOI怎么找? 1505071
科研通“疑难数据库(出版商)”最低求助积分说明 695572
邀请新用户注册赠送积分活动 694860